Aster DM Quality Care Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Aster DM Quality Care reported its first combined proforma results after the merger of Aster DM Healthcare and Quality Care, with revenue up 20% year-on-year to Rs 2,597 crores and EBITDA up 30% to Rs 576 crores in Q1 FY27. Management attributed growth to higher patient volumes, improved case mix, occupancy expansion, and strong growth in medical value travel revenue. Aster DM Healthcare standalone revenue grew 22% to Rs 1,311 crore while Quality Care revenue grew 19% to Rs 1,287 crore, both with margin expansion.
Aster DM Healthcare reported Q4 FY26 revenue of INR 1,182 crores, up 18% year-on-year, with operating EBITDA of INR 244 crores, up 26%, and margins of 20.7%. Management also presented combined proforma performance with Quality Care India Limited (QCIL), which reported revenue of INR 1,178 crores in Q4 FY26 with EBITDA of INR 272 crores, as the proposed merger progressed to the final NCLT approval stage. Both companies detailed cluster-wise performance, capacity expansion plans, and cost synergies, including a Kerala nurses' wage settlement reached during the quarter.